Table 2 Experimental design for in vivo anti-diabetic study
Groups | Treatment |
|---|---|
Group 1 | Control |
Group 2 | Diabetic control (streptozotocin 45 mg/kg b.wt) |
Group 3 | Diabetic rats treated with glibenclamide (2 mg/kg b.wt) |
Group 4 | Diabetic rats treated with FNW |
Group 5 | Diabetic rats treated with LRR |
Group 6 | Diabetic rats treated with LRS |
Group 7 | Diabetic rats treated with HAR |